Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study.
about
An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug.Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study.Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.Disease-Modifying Therapies and Adherence in Multiple Sclerosis: Comparing Patient Self-Report with Pharmacy Records.Adherence to disease-modifying therapies in patients with multiple sclerosis
P2860
Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Determinants of non-adherence ...... ross-Canada prospective study.
@ast
Determinants of non-adherence ...... ross-Canada prospective study.
@en
type
label
Determinants of non-adherence ...... ross-Canada prospective study.
@ast
Determinants of non-adherence ...... ross-Canada prospective study.
@en
prefLabel
Determinants of non-adherence ...... ross-Canada prospective study.
@ast
Determinants of non-adherence ...... ross-Canada prospective study.
@en
P2093
P2860
P50
P356
P1476
Determinants of non-adherence ...... ross-Canada prospective study.
@en
P2093
CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS)
Charity Evans
John D Fisk
Kirsten Fiest
Ruth Ann Marrie
Trudy Campbell
P2860
P304
P356
10.1177/1352458516657440
P577
2016-06-29T00:00:00Z